TABLE 4.
Strain | Tn5lac insertionb | Timing (h)c | Dependenced | CF + d-cycloserinee |
---|---|---|---|---|
DK5285 | Ω4491 | 0 | asg | Same |
DK4300 | Ω4408 | 1 | Partial bsg | Same |
DK4521 | Ω4521 | 2 | asg | Same |
DK5206 | Ω4455 | 3 | Partial bsg | Early |
DK4469 | Ω4469 | 5 | Partial bsg | Same |
DK4290 | Ω4273 (tps) | 5 | asg | Same |
DK4514 | Ω4514 | 9 | Partial csg | Early |
DK5274 | Ω4414 | 10 | bsg | Same |
DK4368 | Ω4403 | 15 | csg | Same |
DK5204 | Ω4435 | 25 | csg | Same |
DK4293 | Ω4401 | 30 | csg | Same |
All strains are in a DK1622 background. The strains were incubated at 28°C for development as described in Materials and Methods. Plates were monitored for appearance of a blue precipitate. d-Cycloserine was added at 15 μg/ml.
Ω4408 is a mutation that causes delayed aggregation. Ω4414 is a mutation that causes poor aggregation. The rest of the Tn5lac insertions have no developmental defect (30).
The time at which Tn5lac insertions are expressed is taken from Kroos et al. (30) and was determined by spectrophotometric assays of β-galactosidase in extracts of developing cells.
The expression of Tn5lac insertions in Asg, Bsg, and Csg mutant backgrounds was monitored to determine the effects of these mutations on the expression of the Tn5lac insertions (31, 34).
Time at which blue precipitate was detected in comparison to CF plates (no d-cycloserine). As described in Materials and Methods, the plates were examined daily for the appearance of blue precipitate. This method is not as sensitive as that used by Kroos, et al. (30) to determine the time at which the genes are first expressed (see note b), but the sensitivity is sufficient to detect significant differences in the onset or level of expression.